Package | us.nlm.vsac |
Resource Type | ValueSet |
Id | 2.16.840.1.113762.1.4.1178.27 |
FHIR Version | R4 |
Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1178.27/expansion |
URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27 |
Version | 20220716 |
Status | active |
Date | 2022-07-16T01:02:12-04:00 |
Name | ARNITherapy |
Title | ARNI Therapy |
Realm | us |
Authority | hl7 |
Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for medications of angiotensin receptor–neprilysin inhibitor (ARNI) therapies.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for angiotensin receptor–neprilysin inhibitor (ARNI) therapy.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs, components or ingredients.) |
No resources found
CodeSystem | |
rxnorm | RxNorm |
No narrative content found in resource
{ "resourceType": "ValueSet", "id": "2.16.840.1.113762.1.4.1178.27", "meta": { "versionId": "5", "lastUpdated": "2023-12-21T17:43:03.000-05:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ] }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-author", "valueContactDetail": { "name": "AHA Author" } }, { "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate", "valueDate": "2025-03-10" }, { "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate", "valueDate": "2022-07-16" } ], "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.27", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113762.1.4.1178.27" } ], "version": "20220716", "name": "ARNITherapy", "title": "ARNI Therapy", "status": "active", "experimental": false, "date": "2022-07-16T01:02:12-04:00", "publisher": "AHA Steward", "jurisdiction": [ { "coding": [ { "system": "urn:iso:std:iso:3166", "code": "US" } ] } ], "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for medications of angiotensin receptor–neprilysin inhibitor (ARNI) therapies.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication for angiotensin receptor–neprilysin inhibitor (ARNI) therapy.),(Exclusion Criteria: Excludes concepts that represent non-prescribable, branded drugs, components or ingredients.)", "compose": { "include": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "concept": [ { "code": "1656340", "display": "sacubitril 24 MG / valsartan 26 MG Oral Tablet" }, { "code": "1656349", "display": "sacubitril 49 MG / valsartan 51 MG Oral Tablet" }, { "code": "1656354", "display": "sacubitril 97 MG / valsartan 103 MG Oral Tablet" } ] } ] }, "expansion": { "identifier": "urn:uuid:b0a0596a-1061-4a4d-b82f-17b752fe3461", "timestamp": "2025-05-23T19:07:47-04:00", "total": 3, "contains": [ { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1656340", "display": "sacubitril 24 MG / valsartan 26 MG Oral Tablet" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1656349", "display": "sacubitril 49 MG / valsartan 51 MG Oral Tablet" }, { "system": "http://www.nlm.nih.gov/research/umls/rxnorm", "version": "05052025", "code": "1656354", "display": "sacubitril 97 MG / valsartan 103 MG Oral Tablet" } ] } }